发展战略 |
|
|
|
|
我国人类遗传资源采集活动现状分析与对策建议* |
赵添羽1,华玉涛1,何蕊1,卢彦崑2,谭华璐1,宋润泽1,沈建忠1,**() |
1 中国生物技术发展中心 北京 100039 2 河北省科技创新服务中心 石家庄 050021 |
|
Status Analysis and Suggestions of Collecting Human Genetic Resources in China |
ZHAO Tian-yu1,HUA Yu-tao1,HE Rui1,LU Yan-kun2,TAN Hua-lu1,SONG Run-ze1,SHEN Jian-zhong1,**() |
1 China National Center for Biotechnology Development, Beijing 100039, China 2 Hebei Science and Technology Innovation Service Center, Shijiazhuang 050021, China |
引用本文:
赵添羽,华玉涛,何蕊,卢彦崑,谭华璐,宋润泽,沈建忠. 我国人类遗传资源采集活动现状分析与对策建议*[J]. 中国生物工程杂志, 2022, 42(5): 139-145.
ZHAO Tian-yu,HUA Yu-tao,HE Rui,LU Yan-kun,TAN Hua-lu,SONG Run-ze,SHEN Jian-zhong. Status Analysis and Suggestions of Collecting Human Genetic Resources in China. China Biotechnology, 2022, 42(5): 139-145.
链接本文:
https://manu60.magtech.com.cn/biotech/CN/10.13523/j.cb.2203050
或
https://manu60.magtech.com.cn/biotech/CN/Y2022/V42/I5/139
|
[1] |
李萍萍, 潘子奇. 我国人类遗传资源保护与利用的现状分析. 中国新药杂志, 2018, 27(23): 2731-2734.
|
|
Li P P, Pan Z Q. Status analysis of the protection and utilization of human genetic resources in China. Chinese Journal of New Drugs, 2018, 27(23): 2731-2734.
|
[2] |
石锦浩, 黎爱军. 人类遗传资源管理与生物安全现状. 解放军医院管理杂志, 2019, 26(8): 712-714.
|
|
Shi J H, Li A J. Status quo of human genetic resources management and biosafety. Hospital Administration Journal of Chinese PLA, 2019, 26(8): 712-714.
|
[3] |
何蕊, 董妍, 刘静, 等. 典型人类遗传资源管理模式及对我国的启示. 中国医药生物技术, 2018, 13(6): 566-568.
|
|
He R, Dong Y, Liu J, et al. Typical human genetic resources management model and its enlightenment for China. Chinese Medicinal Biotechnology, 2018, 13(6): 566-568.
|
[4] |
中华人民共和国人类遗传资源管理条例. 中华人民共和国国务院公报, 2019(18): 29-35.
|
|
The State Council. Regulations of the People’s republic of China on administration of human genetic resources. Gazette of the State Council of the People’s Republic of China, 2019(18): 29-35.
|
[5] |
周燕, 任宇, 杨宏昕, 等. 药物临床试验实施中涉及人类遗传资源管理的实践与思考. 中国医药导报, 2019, 16(28): 174-176, 185.
|
|
Zhou Y, Ren Y, Yang H X, et al. The practice and thinking of human genetic resources management in drug clinical trial implementation. China Medical Herald, 2019, 16(28): 174-176, 185.
|
[6] |
胡爱珍, 张雪, 齐苗苗, 等. 人类遗传资源管理的现状与实践思考. 中国医药生物技术, 2021, 16(6): 556-558.
|
|
Hu A Z, Zhang X, Qi M M, et al. Current situation and practice of human genetic resource management. Chinese Medicinal Biotechnology, 2021, 16(6): 556-558.
|
[7] |
禇嘉祐. 中国人类遗传资源的研究和管理. 科学, 2020, 72(2): 5-10,4.
doi: 10.1126/science.72.1853.5
|
|
Chu J Y. Research and management of human genetic resources in China. Science, 2020, 72(2): 5-10,4.
doi: 10.1126/science.72.1853.5
|
[8] |
苏月, 何蕊, 王跃, 等. 加强我国人类遗传资源保护和利用. 中华临床实验室管理电子杂志, 2017, 5(1): 9-11.
|
|
Su Y, He R, Wang Y, et al. Strengthen the protection and utilization of human genetic resources in China. Chinese Journal of Clinical Laboratory Management (Electronic Edition), 2017, 5(1): 9-11.
|
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
|
Shared |
|
|
|
|
|
Discussed |
|
|
|
|